MEDULTIMA ADVENTURE SUNSCREEN

Manufacturer
Guangzhou Tata Biotechnology Co., Ltd.
Effective date
2026-06-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-06-11 05:10:26

Label at a glance#

ProductMEDULTIMA ADVENTURE SUNSCREEN
Active ingredientOCTOCRYLENE, ETHYLHEXYL SALICYLATE, PHENYLBENZIMIDAZOLE SULFONIC ACID, BUTYL METHOXYDIBENZOYLMETHANE, HOMOSALATE
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Homosalate 9% ………………………… Sunscreen
Octocrylene 7% …………………………… Sunscreen
Phenylbenzimidazole Sulfonic Acid 4% …… Sunscreen
Ethylhexyl Salicylate 4% ………………………… Sunscreen
Butyl Methoxydibenzoylmethane 3% ………… Sunscreen

OTC - PURPOSE SECTION

Sunscreen

INDICATIONS & USAGE SECTION

helps prevent sunburn

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin.

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center immediately.

DOSAGE & ADMINISTRATION SECTION

Directions

• Apply liberally to face and neck 15 minutes before sun exposure

• Use a water-resistant sunscreen if swimming or sweating

• Reapply at least every 2 hours

• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including:

• Limit time in the sun, especially from10 a.m.-2 p.m.

• Wear long-sleeved shirts, pants, hats, and sunglasses • Children under 6 months: Ask a physician

INACTIVE INGREDIENT SECTION

Inactive ingredients Water, Butylene Glycol, Titanium Dioxide, Isononyl Isononanoate, Cetearyl Alcohol, Dimethicone, Glyceryl Stearate, Niacinamide, PEG-100 Stearate, Sodium Hydroxide, Potassium Cetyl Phosphate, Silica, Pentylene Glycol, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Cetearyl Glucoside, Hydroxyacetophenone, Phenoxyethanol, Arginine, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Caprylyl Glycol, Trehalose, Fragrance, Xanthan Gum, Tranexamic Acid, Disodium EDTA, Gentiana Scabra Root Extract, Tocopherol, Polysorbate 60, Sorbitan Isostearate, Phenylethyl Resorcinol, Hydroxyphenyl Propamidobenzoic Acid, Carnosine, Ascorbyl Palmitate.

OTHER SAFETY INFORMATION

protect the product from excessive heat and direct sun

OTC - QUESTIONS SECTION

You can email us at medultima@yahoo.com, for more help!

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 40 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84066-10984066-109-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 38 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEDULTIMA ADVENTURE SUNSCREENHOMOSALATE,OCTOCRYLENE, PHENYLBENZIMIDAZOLE SULFONIC ACID, ETHYLHEXYL SALICYLATE, BUTYL METHOXYDIBENZOYLMETHANEGuangzhou Tata Biotechnology Co., Ltd.5368b2b3-fd80-9659-e063-6394a90a0ad32026-06-04WarningsExact identifier
ndc (package): 84066-109-01
ndc (product): 84066-109
ndc11 (package): 84066010901
spl id: 5368b2b3-fd81-9659-e063-6394a90a0ad3
spl set id: 5368b2b3-fd80-9659-e063-6394a90a0ad3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.